| Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients C Pozzo, M Basso, A Cassano, M Quirino, G Schinzari, N Trigila, ... Annals of Oncology 15 (6), 933-939, 2004 | 419 | 2004 |
| Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study) C Pinto, F Di Fabio, C Barone, S Siena, A Falcone, S Cascinu, ... British journal of cancer 101 (8), 1261-1268, 2009 | 215 | 2009 |
| Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases C Barone, G Nuzzo, A Cassano, M Basso, G Schinzari, F Giuliante, ... British journal of cancer 97 (8), 1035-1039, 2007 | 155 | 2007 |
| Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil M Ciaparrone, M Quirino, G Schinzari, G Zannoni, DC Corsi, FM Vecchio, ... Oncology 70 (5), 366-377, 2007 | 143 | 2007 |
| Are markers of systemic inflammation good prognostic indicators in colorectal cancer? S Rossi, M Basso, A Strippoli, G Schinzari, E D'Argento, M Larocca, ... Clinical colorectal cancer 16 (4), 264-274, 2017 | 113 | 2017 |
| Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study AO Siefker-Radtke, A Necchi, SH Park, J García-Donas, RA Huddart, ... The Lancet Oncology 23 (2), 248-258, 2022 | 104 | 2022 |
| Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma G Ianiro, E Rossi, AM Thomas, G Schinzari, L Masucci, G Quaranta, ... Nature communications 11 (1), 4333, 2020 | 103 | 2020 |
| Hormone receptor status and HER2 expression in primary breast cancer compared with synchronous axillary metastases or recurrent metastatic disease S Rossi, M Basso, A Strippoli, V Dadduzio, E Cerchiaro, R Barile, ... Clinical breast cancer 15 (5), 307-312, 2015 | 96 | 2015 |
| Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: data from a large international cohort study G Rindi, C Klersy, L Albarello, E Baudin, A Bianchi, MW Buchler, M Caplin, ... Neuroendocrinology 107 (4), 375-386, 2019 | 92 | 2019 |
| Reduced expression and altered subcellular localization of the cyclin‐dependent kinase inhibitor p27Kip1 in human colon cancer A Sgambato, C Ratto, B Faraglia, M Merico, R Ardito, G Schinzari, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 1999 | 91 | 1999 |
| Pembrolizumab as first-line treatment for metastatic uveal melanoma E Rossi, MM Pagliara, D Orteschi, T Dosa, MG Sammarco, CG Caputo, ... Cancer Immunology, Immunotherapy 68, 1179-1185, 2019 | 78 | 2019 |
| Tailored immunotherapy approach with nivolumab in advanced renal cell carcinoma (TITAN-RCC) MO Grimm, M Schmidinger, ID Martinez, G Schinzari, E Esteban, ... Annals of Oncology 30, v892, 2019 | 65 | 2019 |
| Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer C Barone, M Basso, G Schinzari, C Pozzo, N Trigila, E D'Argento, ... Gastric cancer 10, 104-111, 2007 | 61 | 2007 |
| Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review L Tagliaferri, V Lancellotta, B Fionda, M Mangoni, C Casà, A Di Stefani, ... Human Vaccines & Immunotherapeutics 18 (3), 1903827, 2022 | 59 | 2022 |
| Expression of vascular endothelial growth factor, mitogen-activated protein kinase and p53 in human colorectal cancer. A Cassano, C Bagalà, C Battelli, G Schinzari, M Quirino, C Ratto, ... Anticancer research 22 (4), 2179-2184, 2002 | 59 | 2002 |
| TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway IG Zizzari, C Napoletano, A Botticelli, S Caponnetto, F Calabrò, A Gelibter, ... Cancer immunology research 6 (6), 711-722, 2018 | 55 | 2018 |
| Primary renal angiosarcoma: A rare malignancy. A case report and review of the literature☆ L Leggio, G Addolorato, L Abenavoli, A Ferrulli, C D’Angelo, A Mirijello, ... Urologic Oncology: Seminars and Original Investigations 24 (4), 307-312, 2006 | 54 | 2006 |
| Skin cancer triage and management during COVID‐19 pandemic L Tagliaferri, A Di Stefani, G Schinzari, B Fionda, E Rossi, L Del Regno, ... Journal of the European Academy of Dermatology and Venereology 34 (6), 1136-1139, 2020 | 50 | 2020 |
| Influenza vaccine indication during therapy with immune checkpoint inhibitors: a transversal challenge. The INVIDIa study M Bersanelli, D Giannarelli, P Castrignanò, G Fornarini, S Panni, ... Immunotherapy 10 (14), 1229-1239, 2018 | 50 | 2018 |
| Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer C Barone, A Cassano, C Pozzo, D D’Ugo, G Schinzari, R Persiani, ... Oncology 67 (1), 48-53, 2004 | 50 | 2004 |
